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The Laboratory of Environmental Mutagenesis
(LEM) is one of the three scientific laboratories at
the National Institute of Environmental Health
Sciences.
In the formation of the programs for such a
laboratory, it is important to set some goals and
then start to ask the "how and why" questions.
The societal goal for the LEM is the prevention
of increased frequency of genetic disease in the
human population. That goal covers the waterfront;
however, the LEM cannot possibly cover all the
scientific areas necessary to accomplish that goal.
Independently ofhow large we will grow, there will
be areas left out.
The next questions then become, "Which parts
are we going to do and how are we going to do
them?" Our approaches include: (1) development
of short-term testing systems for mutagenic activ-
ity, (2) development of mammalian mutation sys-
tems which can be used to predict the risk for the
human population, (3) development of monitoring
systems for detection of mutations in the human
population, and (4) evaluation ofthe fitness ofpopu-
lations with an increased number of mutations in
the gene pool.
With regard to development of short-term tests
for mutagenesis screening, some pollutants in the
environment are neither mutagenic nor car-
cinogenic by themselves but can be converted by
mammalian metabolism to highly reactive and
genetically active metabolites. Microorganisms
have only a fraction of the toxification-de-
toxification mechanisms that a mammal has. To
screen for mutagenicity in mammals, however, is
extremely expensive and time-consuming, whereas
many quantitative mutation systems exist today in
microorganisms. Therefore, in the development of
the short-term tests we have to combine the micro-
bial mutation system with the drug metabolism of
the higher animal. This can be done by homogeniz-
ing organs of laboratory animals and preparing var-
ious enzyme fractions and testing them for their
ability to form active metabolites from non-active
parent compounds. But by homogenizing an organ
and fractionating it into various parts, the efficiency
ofthe activation pathways and balance between the
toxification and detoxification mechanisms may be
destroyed. This problem can be avoided by inject-
ing the indicator organism into the bloodstream of
the animal and treating the animal with the com-
pound under test and later isolating the micro-
organism and measuring mutations in them.
The microorganisms, however, are not inert
components, lacking any metabolism. Since they do
have their own activation and detoxification sys-
tems, it is very important to know which part ofthe
activation is due to the microorganism and which
part is due to mammalian metabolism. This problem
is being studied in the LEM in collaboration with
the Laboratory of Pharmacology.
Because microorganisms have a cell wall which
can prevent penetration of the cells by certain
chemicals, some chemicals which are active in
mammalian cells are inactive in microorganisms.
To circumvent this problem in the microbial tests,
we are attempting to isolate yeast cells which are
more permeable.
Microbial systems alone obviously cannot be
used to predict the genetic hazard to the human
population from exposure to environmental agents.
Mammalian systems are also required.
One of the very important mutation systems in
mammals is the measurement of induced transmis-
sible translocations. In the government document
on mutagenesis it is stated that if a compound in-
creases the frequency oftranslocation in mammals,
it is to be considered as a human mutagen. This is
the type of chromosomal mutations in the human
population that may result in various types of men-
tal retardation. Presently we are studying the effect
of the unbalanced genome in the offspring of a
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the embryo. Hopefully, these studies will lead to a
much deeper understanding of the hazard to the
health of offspring of the individuals carrying vari-
ous types of translocations.
A new mammalian mutation system has been de-
veloped; namely, the biochemical specific locus
mutation system in which mutations can be de-
tected in specific enzymes. At present, we are only
working with nine different genes, but have a breed-
ing program with The Jackson Laboratory to in-
crease this number to 50. At present we are studying
the model, triethylenemelamine, in this system and
have isolated many new mutants.
In contrast to other specific locus mutation sys-
tems in mammals, the biochemical specific locus
mutation system has a close parallel in man; be-
cause humans and mice have many of the same en-
zymes. This system will most likely add to our abil-
ity to make predictions about the genetic hazard of
a certain compound to the human population from
our animal data.
In order to do this with even more reliability, we
havejust started a unit for sequencing proteins and
later RNA and DNA. This unit will also sequence
the mutant proteins to identify the genetic altera-
tions in mutants. The different types of genetic al-
terations could have quite different effects on the
individuals which carry them. Dr. Neel, in Ann
Arbor, Michigan, is trying to monitor the human
population for mutations by enzyme analysis. Many
of the enzymes in which we are measuring muta-
tions overlap with Dr. Neel's battery of enzymes.
To a certain degree we are providing the back-
ground data which will help to evaluate the findings
in the human population.
Knowingly or unknowingly, fractions of the
human population are exposed to hazardous com-
pounds. It is important, therefore, to have a system
for detection ofmutations in the human population.
Let us first consider Neel's system in which the
offspring are screened in order to determine the
mutant frequency of the parents. This system re-
quires babies from perhaps a million people to come
up with any statistical significance on a reasonable
increase in mutation frequency. This system can
give a general trend in the population; and while
that is important, the epidemiological unit we are
working with is too gross to pinpoint specific
hazardous environments smaller in area than New
York. This problem occurs because the individual
is just one event. If instead we could estimate the
mutation frequency on an individual we would be in
much better shape. To do this we are developing
systems to measure mutations in single cells in vivo.
Here we are limited too; the only two types of sam-
ples of single cells we can get easily from humans
are cells in blood and semen.
In collaboration with Dr. Stamatoyannopoulos at
the University ofWashington, Seattle, we have de-
veloped a technique for detecting RBC's which
carry the sickle cell hemoglobin. The technique is
based on development of monospecific antibodies
to S hemoglobin and labeling it with a fluorescent
molecule. The only cell which will react with this
antibody is the sickle cell. In any normal individual
there are approximately 10-7 sickle cells. This
number could be expected to go up by exposure to
mutagens. The mutation which results in S
hemoglobin is only one type of many hemoglobin
variants. Dr. Stamatoyannopoulos, therefore, is
making antibodies to many other hemoglobin mu-
tants. This will increase the sensitivity of the sys-
tem. In order to interpret the data we need animal
model systems. Various strains ofmice contain dif-
ferent hemoglobins and we are utilizing these dif-
ferences to develop such model systems.
Around the midpiece of sperm is a sheet of
mitochondria containing enzymes which can be de-
tected by histochemical stains. By using specific
inhibitors of these enzymes, it may be possible to
detect mutation resistance to the inhibitor. I hope to
use this mutation detecting technique to develop a
monitoring system for the human population.
One ofthe advantages ofthe RBC system and the
sperm system is that both are nondestructive to the
animal and the detection of mutations, therefore,
can piggyback on any bigger chronic feeding study.
In this way the mutation frequencies also can be
correlated with other toxicological phenomena such
as tumorgenesis, etc. When this correlation is
known, the monitoring system based on detection
ofmutants in the RBC's could also serve as an early
warning system for certain cancers in the human
population.
There are many harmful chemicals that we can-
not avoid in the environment; some ofthese may be
mutagenic. The human society must set limits to
chemical exposure as was done for irradiation. In
order to evaluate the health hazard imposed on the
human population by an increase in mutation fre-
quency, we must evaluate the fitness of individ-
uals carrying these mutations in their genome.
Drosophila is the only available organism in which
this can be done. In the Population Genetics Sec-
tion we are comparing the fitness of the mutations
which exist in the natural population and, therefore,
has been exposed to some selection with the fitness
of newly induced mutations. The data which will
come out of these comparisons should help us
evaluate the genetic hazard imposed on the human
population by exposure to mutagens.
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